Blood Journal/X
Jun 7, 2025, 10:28
IL-10 From Tumoral B Cells Modulates the Diffuse Large B-Cell Lymphoma Microenvironment and Response to Immunotherapy
The Blood Journal featured a post highlighting the published article on X:
“Hallmarks of IL-10 deficiency predict R-CHOP response but reflect poor antitumor immunity in preclinical models and patients with DLBCL.”
Title: IL-10 from tumoral B cells modulates the diffuse large B-cell lymphoma microenvironment and response to immunotherapy
Authors: Marcos Garcia-Lacarte, Sara C. Grijalba, Javier Melchor, Marién Pascual, Enrique Goñi, Iñigo Clemente-Larramendi, Sandra Morales-Sánchez, María A. Burrell, Oscar Blanco, Adrián Arnaiz-Leché, Blanca S. Berrozpe, Maria Amann, Christian Klein, Pablo Umaña, Miguel Canales, José Ángel Martínez-Climent, Juan J. Lasarte, Pablo Sarobe, Francisco J. Novo, Sergio Roa
Find more posts on Hemostasis Today.
-
May 24, 2026, 17:48Flora Peyvandi: Crucial Role of Placental ADAMTS13 in Perinatal Survival
-
May 24, 2026, 17:13Mahtab Mashayekhi: The Evolving Role of Red Blood Cell Exchange in the Management of SCD
-
May 24, 2026, 17:12Silvina Graña: Helping Families Better Understand Hemophilia and Daily Life With Bleeding Disorders
-
May 24, 2026, 17:11Miikka Vikkula: Key Insights from the ISSVA 2026 World Congress
-
May 24, 2026, 17:10Mathieu Jackson: Proud to Be Present at This Historic Moment for the Global Bleeding Disorders Community
-
May 24, 2026, 17:09Ramina Fazeli: Highlighting the Emerging Role of Neutrophil Extracellular Traps in Ovarian Cancer
-
May 24, 2026, 16:12William Wallace: Normal B12 Levels May Still Cause Brain Damage and Cognitive Decline
-
May 24, 2026, 15:54Marc Carrier: Ottawa Race Weekend Raised Over 7,000 USD for Thrombosis Canada
-
May 24, 2026, 15:44Janak Sadhu: Building a Stroke-Free Mehsana Through Community Awareness and Healthcare Collaboration